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Abstract
Background: Non-steroidal anti-inflammatory drugs (NSAIDs), transdermal fentanyl patches, and transmucosal
buprenorphine are probably the most commonly used options for providing post-operative analgesia in the early
at-home period. However, these require daily administration or are associated with abuse concerns. One of the
significant unmet needs in veterinary surgery and pain management is for longer acting opioids for cats to effectively
bridge the gap between the in-hospital and at-home recovery periods.
A proof of concept study of an extended release formulation of buprenorphine HCL (ER-Bup) was conducted using
objective kinetic measures and a unilateral onychectomy model. Using a blinded, randomized, two period crossover
design, four cats were allocated to control (saline) or ER-Bup (0.6 mg/kg, subcutaneously [SC]) treatment groups. All
animals underwent a unilateral forelimb onychectomy per period with a washout/recovery period in between.
Observational pain scores and kinetic data (using a pressure sensitive walkway [PSW]) were collected prior to
(baseline) and at intervals for 72 h following surgery. Symmetry indices were derived for kinetic variables
(peak vertical force [PVF]; vertical impulse [VI]) of each forelimb for landing following a jump and for walking.
A rescue analgesic protocol was in place. Effect of surgery and treatment were evaluated using a mixed
model statistical approach.
Results: No cats required rescue analgesics based on subjective pain score. ER-Bup had a positive influence
on subjective pain scores during the 72 h postsurgery (p = 0.0473). PVF and VI of the operated limb were
significantly decreased for both landing (p < 0.0001 and p < 0.0001) and walking (p < 0.0001 and p < 0.0001
respectively) compared to control. ER-Bup resulted in significantly decreased asymmetry in limb use during
landing (PVF, p < 0.0001; VI, p < 0.0001) and walking (PVF, p = 0.0002, VI, p < 0.0001). The novel use of data
collected following a jump from an elevated platform appeared to provide all desired information and was
easier to collect than walking data.
Conclusion: This study demonstrates that SC administration of ER-Bup may be an effective analgesic for a 72 h period
postoperatively. Furthermore, landing onto a PSW from an elevated perch may be a useful and efficient way to assess
analgesics in cats using a unilateral model of limb pain.
Keywords: Buprenorphine, Extended release, Pressure sensitive walkway, Landing, Cat, Kinetic
* Correspondence: duncan_lascelles@ncsu.edu
1Comparative Pain Research Laboratory Department of Clinical Sciences,
College of Veterinary Medicine, North Carolina State University, Raleigh, NC,
USA
5Comparative Medicine Institute, North Carolina State University, Raleigh, NC
27606, USA
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Enomoto et al. BMC Veterinary Research  (2017) 13:32 
DOI 10.1186/s12917-017-0943-5
Background
Inadequate control of pain in the perioperative period in
cats has been linked to poor recoveries, postoperative com-
plications and potentially chronic pain [1]. Non-steroidal
anti-inflammatory drugs (NSAIDs), transdermal fentanyl
patches, and transmucosal buprenorphine are probably the
most commonly used options for providing post-operative
analgesia in the early at-home period [2]. However, there
are concerns about side effects of NSAIDs; there are po-
tential abuse concerns with sending fentanyl patches into
the home environment [3]; and transmucosal buprenor-
phine is not always easy for owners to accomplish [2]. One
of the significant unmet needs in veterinary surgery and
pain management is for longer acting opioids for cats to
effectively bridge the gap between the in-hospital and at-
home recovery periods.
Buprenorphine, a synthetic opioid drug that is classi-
fied as a partial μ opioid receptor agonist, is commonly
used for pain management in cats via multiple adminis-
tration routes [4, 5]. This drug reportedly has a strong
affinity for, and dissociates slowly from, the mu opioid
receptors [6]. Because of this pharmacodynamic profile,
the immediate release formulation of buprenorphine is
considered to be one of the longest-acting opioids avail-
able with a duration of action greater than 6 h [7, 8].
Additionally, the incidence of undesirable side effects,
such as vomiting, nausea, respiratory depression and
dysphoria, is reportedly lower compared to other opioids
[2]. Due to these characteristics, it has become one of
the most popular opioid analgesics for use in cats in
many countries [9, 10]. A recent clinical study, however,
did illustrate that cats undergoing ovariohysterectomy
may require a second dose of buprenorphine 4 h after
surgery [11]. This, and other data, suggests that a single-
injection is not sufficient for effective postoperative pain
relief [5, 12].
It is well established that it is difficult to recognize and
measure pain in cats [1, 13]. Multiple methods attempting
to accurately assess pain have been described [14, 15],
and several research groups are in the process of develop-
ing and validating subjective pain scales for clinical use
[14, 16–18]. One objective method to evaluate pain is gait
analysis, which is only relevant if the origin of the pain
affects gait. Pressure sensing platforms, or pressure sensi-
tive walkways (PSW) have been investigated for the meas-
urement of limb use in cats [19, 20] and used for the
evaluation of limb use following onychectomy [21]. It is
difficult to collect high quality limb use data when relying
solely on cats freely walking across a PSW in a straight
line (unpublished observations).
Several years ago kinetic evaluation of jumping cats
using a PSW was proposed by our pain research group
at NC State [20] and recently revisited by another team
of researchers [19]. One potential use of this method is
to measure the left-right difference in kinetic parameters
when there is unilateral forelimb pain.
The availability of an extended release formulation of
buprenorphine (ER-Bup) may provide effective analgesia
in the immediate postoperative period in the hospital
and at-home. Evaluation of an extended release formula-
tion of buprenorphine in dogs undergoing arthrotomy
provided pain relief over a 72 h period [22]. In cats, it
has been reported that the administration of a single
dose of ER-Bup had a similar efficacy (as evaluated by
subjective pain assessment scales) and adverse effect pro-
file as twice-daily oral transmucosal administration of
buprenorphine [23]. However, there was no placebo con-
trol group in this study, and the investigators did not use a
validated subjective assessment tool, and so the efficacy of
the new formulation of buprenorphine is unknown.
The aim of the present study was to perform a pilot
proof of principle pilot study of ER-Bup using objective
kinetic measures collected from walking, and landing
following a jump from an elevated perch (0.7 m), in a
unilateral onychectomy model. It was hypothesized that
unilateral onychectomy would result in asymmetry of
forelimb kinetic values in cats, and that ER-Bup would
decrease this asymmetry. Further, it was hypothesized
that collecting data from cats landing from an elevated
platform (jumping down) would result in measureable
objective parameters similar to the classical collection of
kinetic variables in freely ambulating cats.
Methods
Study design
The study was an experimental, masked, randomized,
placebo controlled, two period cross-over design. The in-
vestigator, surgeon and any others involved in making
assessments regarding product efficacy or safety were un-
aware of treatment assignment. The study monitor and
dose administrator were un-masked but were not involved
in clinical assessments. The cats were housed in a climate-
controlled facility in compliance with the U.S Animal
Welfare Act. All study procedures were approved by the
Institutional Animal Care and Use Committee (protocol
number PLRS 1006). The study was initiated at Professional
Laboratory and Research Services, Inc.
Animals
Four purpose-bred mature domestic short-hair sexually
intact two male and two female cats were used. They
were considered healthy based on physical examination,
complete blood count, serum biochemical analysis, and
urinalysis. Body weights ranged from 2.2 to 3.2 kg. Age
of all cats was approximately 10 months old. The cats
were housed individually in a room with a controlled en-
vironment and were acclimated to their surroundings
for at least 30 days.
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Treatment and surgical procedures
Treatment groups consisted of a control group (0 mg/
kg; saline) and ER-Bup group (0.6 mg/kg subcutane-
ously, SC). In previous work (unpublished kinetic stud-
ies) 0.6 mg/kg of ER-Bup was confirmed not to cause
significant ataxia, weakness or other impairment that
might be interfere with ability to assess gait or other
treatment during the development of this product. The
cats were randomly allocated to one of the two treat-
ments for each limb. A two period crossover study was
employed to evaluate the two groups as shown in
Table 1. All animals underwent two onychectomy sur-
geries; the first foot during period 1 and the other foot
during period 2 with a washout/recovery period between
(Fig. 1). Cats were deemed ready for a second surgery
when peak vertical force measurements (PVF), both at a
walk and following landing from an elevated platform,
were within the 95% confidence interval of the average
of the two baseline PVF measurements. The same
anesthetic regimen and surgical procedure was used in
each period. As previously described [24], guillotine-type
nail clippers were carefully positioned to completely re-
move the third phalanx. Treatments (saline or ER-Bup)
were administered 20–60 min prior to anesthetic induc-
tion. Four weeks after the first surgery, during the wash-
out/recovery period, kinetic variables were collected at
pre-determined intervals and analyzed. Upon the con-
clusion of the study, each cat had had both forelimbs
declawed with one foot being done with the test article
being incorporated into the pre-operative anesthetic pro-
cedure and the other being done with a negative control.
Anesthesia protocol
Pre-anesthetic medication with acepromazine at 0.03 mg/
kg intramuscularly 20–60 min prior to anesthetic induc-
tion (administered at the same time as the ER-Bup or sa-
line). Intravenous propofol (2–6 mg/kg) was administered
to effect to induce general anesthesia. Isoflurane carried in
O2 was administered via an endotracheal tube for the
maintenance of anesthesia. During anesthesia, cats were
monitored for heart rate, respiration rate, temperature, end
tidal CO2, oxygen saturation, and blood pressure was
measured noninvasively. Vital signs and comfort were
periodically assessed after anesthesia until the cats
were fully recovered from anesthesia and their rectal
temperature was normal.
Collection of kinetic variables using a Pressure Sensitive
Walkway (PSW)
A PSW (7100 QL Virtual Sensor 4Mat System, Tekscan,
Boston, MA), 2.4 m × 0.5 m with 4 sensels/cm2, was
used to collect kinetic data from walking and landing
cats as described previously [20].
The data were recorded at 6, 24, 30, 48, 54, and 72 h
after surgery. Baseline gait analysis was performed for
each animal 24 and 48 h prior to each surgical proced-
ure (Fig. 1). A 50 psi sensor range was selected following
a review of previous work that indicated this was the
most appropriate sensor range [20]. The output data re-
corded was analyzed using proprietary Tekscan software
(Walkway v7.0 software, Tekscan, Boston, MA). Each
day, the whole area of the pressure platform was loaded
and unloaded by walking on it (conditioning), and it was
then equilibrated and calibrated according to the manu-
facturer’s instructions. For all data collection, the frame
acquisition rate was set to the maximum frequency of
60 Hz. All cats underwent daily walking and jumping
down training on the PSW for approximately 30 days
prior to study initiation. Following the washout/recovery
period training sessions were again performed for 12 days
prior to the second surgery. For the collection of walking
data, valid data movies were defined as the cat traversing
the PSW in a straight line, within individualized velocity
and acceleration parameters, with no visually detectable
movement of the head from side to side, and no visually
detectable slowing down or acceleration. Cats were en-
couraged to traverse the mat spontaneously using treats
and toys. Cardboard barriers were sometimes used on ei-
ther side of the PSW to prevent the cats from wandering
off the mat. Ten sets of walking data were collected,
with at a target velocity of 0.6 ± 0.2 m/s and within ac-
celeration changes of ±0.1 m/s2. Either using manual
analysis or automated analysis available within the soft-
ware, the velocity of each ‘run’ was calculated to ensure
there were ten data sets collected within the velocity pa-
rameters set. As described later, post-collection analysis
used the five data sets that were closest to the target
velocity and acceleration parameters to minimize the im-
pact of differences in velocity on kinetic parameters.
Additionally, at each time point, ten sets of data were
collected with the cats landing on the mat after jumping
down from an elevated platform. The cats were encour-
aged to jump down onto the PSW, using treats and toys,
from an elevated platform that was 0.7 m vertical dis-
tance from the ground (and PSW), landing on the PSW
with their forelimbs first (landing data). Valid data
movies were defined as those where cats jumped down
Table 1 Animal allocation and randomization schedule
Cat Treatment
sequence
Period.1 Period.2
Test article Foot Test article Foot
1 1 Saline L ER-Bup R
2 1 Saline R ER-Bup L
3 2 ER-Bup R Saline L
4 2 ER-Bup L Saline R
ER-Bup extended release formulation of buprenorphine HCL
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in a forward direction, and landed with the forelimb(s)
first. Using the software, kinetic data were collected
from each forelimb footfall for each of five valid trials.
PVF and vertical impulse (VI) were collected. All forces
were normalized to and expressed as a percentage of the
cat’s body weight. Forelimb symmetry indices (SI) for
PVF and VI, during both walking and landing were
calculated by use of the following equation [25].
SI ¼ ð
xop−xnoÞ
1=2ð Þ xopþ xnoð Þ  100
Where xop is the mean of a given gait variable for op-
erated limb and xno is the mean of a given gait variable
for non-operated limb. Time between first and second
forelimb strike (Tf1f2) was calculated by subtracting time
of contact of the non-operated limb from time of con-
tact of the operated limb. The number of trials where
there was a measurable difference in the time of first
and time of second forelimb strike (NTf1f2) was counted.
Time between first forelimb and first hindlimb strike
(Tf1h1) was calculated by subtracting time of contact of
first forelimb from time of contact of first hindlimb.
Rescue analgesia
Observational pain assessments were completed at 3, 6,
12, 24, 30, 36, 48, 54, 60, and 72 h after treatment (Fig. 1)
using a subjective scoring system (Additional file 1).
Baseline assessments were made for each animal 24 and
48 h before initial and second surgery. A priori, it was
decided that any cat that with a pain score of four at any
time would be administered rescue analgesia. Pain scores
were assigned by a single trained observer. For cats
requiring rescue analgesia, meloxicam was administered
at a dose of 0.1 mg/kg SC.
Statistical analysis
Statistical analyses were performed using JMP and SAS
(JMP Pro, version 11, SAS 9.4, SAS Institute, Cary NC).
Wilcoxon signed-rank test and a paired t-test were used
to compare the area under the curve minus baseline
(AUC) of pain score versus time between groups. For pain
score versus time curves a logistic regression with re-
peated measures analysis for time and maximum likeli-
hood fitting method was used (PROC GLIMMIX in SAS).
Pain score was treated as an ordinal variable in a logistic
model with treatment group, period, time as main effects
and with interaction terms of time*treatment and period*-
time (See Additional file 2). The GLIMMIX output also
calculated the probability of a score of baseline versus
time for both periods and for both treatment groups. A
predicted time at which a probability of 0.5 was reached,
is similar to an LD50, was obtained (Fig. 3).
Mixed model analysis was conducted to test the effect
of time on the outcome measures in the control group
in order to see if the cats undergone onychectomy had
symmetrical gait. Cat was included as a random effect in
the mixed model. Within each treatment a repeated
measures analysis was used on the six times (6, 24, 30,
48, 54 and 72 h) with a residual option for the covari-
ance structure (see Additional file 3 for a script of the
mixed model parameters and options). Dunnett’s test
was used to compare each time point to the baseline
value. When walking and landing data were compared
between the control group and the ER-Bup group, mixed
model analysis was used to test for the effect of treat-
ment on the outcome measures in this crossover design.
Fig. 1 Schematic outline of the study protocol. Using a blinded, randomized, two period crossover design, four cats were allocated to control
(saline) or ER-Bup (0.6 mg/kg, subcutaneously) treatment groups, in random order. The cats underwent a unilateral forelimb onychectomy per
period with a washout/recovery period between. Observational pain scores and kinetic data were collected prior to (baseline) and at intervals for
72 h following surgery (total of 5 days of data collection). All cats underwent daily walking and jumping training on the PSW for approximately
30 days prior to study initiation. Following the washout/recovery period training sessions were again performed for 12 days prior to surgery. The
washout/recovery period was 81 days
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Cat was included as a random effect in the mixed model
(see Additional file 4 for a script of the mixed model pa-
rameters and options). Within each treatment a repeated
measures analysis was used on the six times (6, 24, 30, 48,
54 and 72 h) with a residual option for the covariance
structure. In this analysis, because of a significant period
effect, each set of baseline data was separated and the
average baseline value of each cat was calculated for each
response measure. The difference between this average
baseline value was subtracted from the measured response
value at each time point in the analysis. Tukey’s test was
used to evaluate treatment effects at each time point. A
Chi-square for independent test was used for NTf1f2.
The values of P < 0.05 were considered significant.
Results
Pain score
No cats were administered rescue analgesia during study
period. No pain scores of greater than two were re-
corded at any time for any cat (Fig. 2). For each cat, the
area under the curve (AUC) of pain score above baseline
versus time for both the control and ER-Bup treatment
was calculated (Table 2). A paired t-test of AUC for con-
trol and ER-Bup group had a p-value of 0.0473, while a
nonparametric test, Wilcoxon signed rank, gave the mini-
mum possible value for four cats, namely 1/16 (0.063).
The pain scores in Fig. 2 were further examined in a
repeated measures logistic model with treatment group,
period, and time as main effects and with interaction
terms of time*treatment and period*time. Both time and
period*time were significant factors (Table 3). The prob-
ability of the pain score being at baseline level versus
time is shown in Fig. 3. The left panel is for the cats that
received the control first and then ER-Bup, while the
right panel is for the reverse sequence, ER-Bup then
Control. For both panels the blue ER-Bup curves quickly
rise toward a high probability of baseline score. The
red control curves are both less than the ER-Bup
curves and have quite different slopes. The horizontal
reference line is a 0.50 probability of baseline score.
Both ER-Bup curves reach the reference line before
6 h, while the left control curves has a crossing time
around 55 h, while the right control curve crossed
around 18 h. The large difference in the crossing
times, similar to an LD-50, is the basis for the signifi-
cant interaction term, period*time.
The cats were all successfully trained to walk across
the PSW, and to jump down onto the PSW. Contempor-
aneous notes showed that the cats were jumping down
onto the PSW after 3 days or training, but required the
full 30 days allotted for training to consistently walk
across the PSW in a straight line.
Landing data: comparison to baseline for control group
All cats satisfactorily completed five trials that could be
analyzed through this study, although two baseline trials
were missing due to technical errors. The outcome mea-
sures calculated for the landing data in control cats are
summarized in Table 4 and Fig. 4, and time points that
were significantly different from baseline are indicated.
PVF and VI were significantly decreased for the operated
limb and increased for the non-operated limb compared
to baseline, and SI for PVF and for VI were significantly
different from baseline in all time points. Tf1f2 and
Fig. 2 Effect of the treatment on subjective pain score. 3D line graphs
demonstrating the subjective pain scores for control (a) and extended
release formulation of buprenorphine HCL (ER-Bup) groups (b) before
and after onychectomy. Time point 0 h is the mean of assessments at 24
and 48 h prior to surgery (baseline). Observational pain assessments were
performed at 3, 6, 12, 24, 30, 36, 48, 54, 60, and 72 h following surgery
Table 2 The area under the curve of pain score above baseline
versus time
Cat Control ER-Bup
1 3 0
2 66 16.5
3 16.5 0
4 28.5 3
ER-Bup extended release formulation of buprenorphine HCL
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Tf1h1 tended to be increased above baseline following
surgery (Table 4).
NTf1f2 was 19 out of 78 trials (24%) in baseline period,
and 59 out of 120 trials (49%) at following surgery
period in control group (P = 0.0045, OR: 2.49).
Landing data: evaluation of treatment effect
The landing data is summarized in Tables 5 and 6 and
Fig. 5. There was a significant treatment effect observed
for all variables except for the Tf1f2. ER-Bup resulted in
significantly greater PVF on the operated limb and
significantly lower PVF on the non-operated limb com-
pared to the control group. ER-Bup resulted in a signifi-
cantly improved symmetry for PVF. ER-Bup also
resulted in a significantly improved symmetry for VI.
However, when compared to baseline, there was a
greater drop in VI on the operated limb in the ER-Bup
group, and a smaller increase in VI on the non-operated
limb, compared to control. At first glance, these data are
counter to the PVF data, but careful review of the data,
including actual values, indicated that following surgery
cats in the ER-Bup group had higher PVF values than
the control group, but lower contact times (see Discus-
sion). VI is the product of force multiplied by time. Al-
though there was not a significant treatment effect on
Tf1f2, values in the ER-Bup group were smaller, indicat-
ing less delay between the two limbs touching the mat
compared to the control group. Tf1h1 (time between first
forelimb and first hindlimb touching the mat) was
longer in the control group than the ER-Bup group,
indicating the hind limbs contacted the ground more
quickly following the first contact of the fore limbs in
the ER-Bup group compared to the control group.
NTf1f2 was 59 out of 120 trials (49%) in the control
group, and 48 out of 120 trials (40%) in ER-Bup group.
There was no significant difference between the two
groups for NTf1f2 (P = 0.15).
Walking data: comparison to baseline for control group
The cats walked across the PSW at a faster velocity than
the a priori target velocity, and so the comfortable speed
Fig. 3 Probability of pain score having a value equal to baseline versus time. The blue line represents the ER-Bup treatment and the red line represents
control treatment. The left panel represents the sequence of saline, then ER-Bup injection, while right panel ER-Bup, then saline injection. Horizontal
reference line at Probability = 0.5. The predicted time at which a probability of 0.5 is reached, similar to an LD50, is around the first time
measurement (3 h) in the ER-Bup group (blue curves) in the left and right graphs. For the control group (red curves) the time for probability of 0.5 is
quite different for the two periods, around 18 for the right graph and 55 for the left graph
Table 3 ANOVA table for repeated measures analysis of pain
score versus time for PROC GLIMMIX
Effect F value Pr > F
Period 1.55 0.2686
Treatment 1.53 0.2714
Time 7.77 0.0069
Time*Treatment 1.14 0.2898
Time*Period 4.61 0.0353
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for traversing the PSW for each cat was considered
acceptable. Postoperatively, some cats refused to walk
across the PSW. In order to try to minimize the influ-
ence of velocity differences on the data, only SI was used
for walking data analysis. Overall, cats traversed the
walkway at 0.94 ± 0.41 (Mean ± SD) m/s in control
group. At least three cats completed four to five trials
that could be analyzed at each time point. One cat
refused to walk at 6 h following surgery (control group)
and another cat (control group) refused to walk except
at 6 h after surgery in period 1. The summary values of
SI for PVF and VI are shown in Table 7 and Fig. 6, and
the time points where values were significantly differ-
ent from baseline are indicated. SI for PVF and for VI
were significantly reduced compared to baseline at all-
time points.
A B
C D
Fig. 4 Landing kinetic data for control group. a Peak vertical force (PVF) for the operated limb (OP) and non-operated (NO) limb; b Vertical impulse
(VI) for OP and NO; c Symmetry indices (SI) for PVF; d SI for VI. Line graphs demonstrating the mean ± SD in control group at various time points before
and after onychectomy (n = 4). Solid line is OP, dotted line is NO. Time point 0 h is the mean of each gait parameter at 24 and 48 h prior to surgery
(baseline). The gait parameters were recorded at 6, 24, 30, 48, 54, and 72 h following surgery. The SI of 0 means there is perfect symmetry between the
forelimbs, the value of −200 means the cat is non-weight bearing on the operated limb. * indicates significant difference from baseline in each
parameter, shown above upper line and below lower line (<0.05)
Table 4 Kinetic data (mean ± SD) collected from control cats that had undergone a unilateral onychectomy and following landing
from an elevated perch
Time OP PVF (%) NO PVF (%) OP VI (%BW/sec) NO VI (%BW/sec) SI PVF SI VI Tf1f2 (sec) Tf1h1 (sec)
P-value <0.0001 0.0064 <0.0001 <0.0001 <0.0001 <0.0001 0.0125 <0.0001
0 189.14 ± 41.78 182.59 ± 52.18 15.02 ± 3.74 14.05 ± 5.30 4.86 ± 16.13 9.58 ± 24.58 (−0.0011 ± 0.012) 0.11 ± 0.024
6 129.07 ± 29.58* 197.07 ± 42.10 12.47 ± 3.76* 22.77 ± 8.27* (−41.42 ± 28.22)* (−52.93 ± 41.52)* 0.0060 ± 0.0094 0.15 ± 0.053*
24 123.98 ± 37.59* 208.88 ± 41.59* 10.54 ± 3.00* 21.99 ± 8.43* (−51.01 ± 40.92)* (−63.33 ± 46.62)* 0.0070 ± 0.0098 0.12 ± 0.014
30 138.75 ± 36.16* 210.07 ± 41.86* 13.27 ± 3.49 23.38 ± 5.44* (−41.43 ± 25.83)* (−54.12 ± 31.04)* 0.011 ± 0.010 0.14 ± 0.014*
48 132.88 ± 34.57* 209.55 ± 57.90* 11.51 ± 3.14* 22.79 ± 9.88* (−43.13 ± 29.78)* (−59.79 ± 30.42)* 0.012 ± 0.010 0.12 ± 0.020
54 105.87 ± 14.16* 209.88 ± 73.06* 9.04 ± 1.34* 24.72 ± 12.49* (−59.72 ± 33.38)* (−80.21 ± 39.60)* 0.018 ± 0.044* 0.12 ± 0.020
72 124.97 ± 23.18* 211.96 ± 58.16* 10.19 ± 1.87* 23.50 ± 9.91* (−49.35 ± 26.43)* (−70.77 ± 33.78)* 0.0090 ± 0.010 0.12 ± 0.020
*indicates significant difference from baseline (<0.05)
OP Operated limb, NO Non-operated limb, PVF Peak vertical force, VI vertical impulse, SI symmetry indices, Tf1f2 Time between first and second forelimb strike,
Tf1h1 Time between first forelimb and first hindlimb strike
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Walking data: evaluation of treatment effect
No cats in ER-Bup group refused to walk across the PSW.
Cats in ER-Bup group traversed the walkway at 1.16 ±
0.36 m/s, which was significantly faster than the control
group (p < 0.0001). The summary values of SI for PVF and
VI are shown in Table 8 and Fig. 7, and the time
points where values were significantly different be-
tween groups are indicated. SI for PVF and VI were
significantly different between the groups, indicating
significantly greater symmetry for these variables in
the ER-Bup group.
Discussion
In this pilot study, pre- and postoperative kinetic data
were collected from 4 cats by encouraging them to walk
freely across a PSW and to jump down on to it
(landing data). The present study showed that SC ad-
ministration of ER-Bup had a positive influence on
subjective pain scores, walking and landing kinetic pa-
rameters, during 72 h postoperatively. These results
should be confirmed in a larger study as the clinical
significance of our results is difficult to judge in a
small pilot study.
To the authors’ knowledge this is the first report that
has used jumping down onto a PSW for evaluation of
limb use following surgery. Landing data from cats that
had undergone onychectomy could be collected from all
cats at all-time points, unlike walking data. In addition,
the landing data appeared to provide desired informa-
tion, and additionally other outcome measures could
be collected, such as Tf1f2, Tf1h1, and NTf1f2. These
are novel outcome measures that intuitively make
sense, especially the time difference between when
the first forelimb hits the ground and the second, but
they require further investigation as valid measures.
The landing data appeared to show the treatment ef-
fect in a similar way to the walking data. Additionally,
landing data were easier to collect, and could be ana-
lyzed more quickly.
The present study highlights the disparity between
subjective pain scores and objective evaluations of limb
use following onychectomy in cats, and if one accepts
Table 6 Landing data (summary variables for postoperative time points compared to baseline) for each treatment group and
tabluation of treatment effects
Treatment groups Treatment effect
Variable Control ER-Bup P-values Group differences at individual time points
PVF OP (−63.97 ± 45.59) (−50.50 ± 37.44) 0.0026* ER-Bup > control at 6, 54 h
NO 23.69 ± 40.23 11.63 ± 37.58 0.0169*
VI OP (−3.89 ± 3.50) (−6.25 ± 3.22) <0.0001* ER-Bup < control at 6, 30, 48, 72 h
NO 8.99 ± 7.23 1.87 ± 4.50 <0.0001* ER-Bup < control at all time points
SI PVF (−52.03 ± 26.02) (−38.72 ± 18.63) <0.0001* ER-Bup > control at 6, 24, 54 h
VI (−72.28 ± 29.47) (−54.96 ± 27.10) <0.0001* ER-Bup > control at 6, 30, 54 h
Tf1f2 0.012 ± 0.021 0.008 ± 0.010 0.076
Tf1h1 0.014 ± 0.029 (−0.015 ± 0.023) <0.0001* ER-Bup < control at all time points
Mean ± SD, *indicates significant difference between groups (<0.05)
OP Operated limb, NO Non-operated limb, PVF Peak vertical force, VI vertical impulse, SI symmetry indices, Tf1f2 Time between first and second forelimb strike,
Tf1h1 Time between first forelimb and first hindlimb strike, ER-Bup extended release formulation of buprenorphine HCL
Table 5 Kinetic data (mean ± SD) collected from ER-Bup treated cats that had undergone a unilateral onychectomy and following
landing from an elevated
Time OP PVF (%) NO PVF (%) OP VI (%BW/sec) NO VI (%BW/sec) SI PVF SI VI Tf1f2 (sec) Tf1h1 (sec)
P-value <0.0001 0.3800 <0.0001 0.0004 <0.0001 <0.0001 0.0002 <0.0001
0 189.57 ± 52.03 173.68 ± 43.23 16.86 ± 5.82 14.75 ± 5.18 7.95 ± 20.60 14.15 ± 31.55 (−0.0005 ± 0.0071) 0.12 ± 0.027
6 156.33 ± 45.68* 180.15 ± 28.05 11.59 ± 3.53* 13.61 ± 2.83 (−17.02 ± 22.82)* (−17.54 ± 34.80)* 0.0090 ± 0.012* 0.11 ± 0.020
24 132.74 ± 48.23* 177.95 ± 37.77 10.80 ± 3.45* 18.34 ± 6.15* (−32.71 ± 28.98)* (−49.02 ± 42.24)* 0.0040 ± 0.0082 0.11 ± 0.017
30 146.57 ± 35.39* 195.21 ± 51.45 11.79 ± 2.45* 17.76 ± 5.46 (−28.07 ± 25.06)* (−36.69 ± 34.91)* 0.007 ± 0.0098* 0.12 ± 0.025
48 128.38 ± 36.61* 186.89 ± 31.34 9.91 ± 3.01* 15.55 ± 3.61 (−38.66 ± 28.26)* (−44.44 ± 37.28)* 0.007 ± 0.0098* 0.10 ± 0.026*
54 136.68 ± 46.94* 183.54 ± 52.03 10.45 ± 2.37* 15.95 ± 5.03 (−30.78 ± 29.88)* (−30.78 ± 29.88)* 0.008 ± 0.010* 0.095 ± 0.017*
72 133.76 ± 47.14* 188.15 ± 28.06 9.12 ± 1.99* 18.49 ± 7.84* (−37.39 ± 32.35)* (−59.57 ± 47.28)* 0.011 ± 0.010* 0.097 ± 0.028*
Mean ± SD, *indicates significant difference from baseline (<0.05)
OP Operated limb, NO Non-operated limb, PVF Peak vertical force, VI vertical impulse, SI symmetry indices, Tf1f2 Time between first and second forelimb strike,
Tf1h1 Time between first forelimb and first hindlimb strike
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that in this situation decreased limb use is an indicator
of pain, our data clearly point to the need for develop-
ment of more sensitive, and valid, subjective measures.
Based on our subjective pain scores assigned by trained
observers, no cats required rescue analgesics in either
group, and the cats looked comfortable at the end of
study. No cat scored greater than two out of five at any
time during the study, and the direct experience of PDK,
DB and BDXL in these studies supports the result that
the cats looked comfortable. That is not to say we be-
lieve these cats are comfortable, on the contrary, our
kinetic data showed large asymmetry in kinetic variables
between the operated and non-operated limbs suggest-
ing discomfort associated with the procedure. However,
this is very difficult to detect subjectively.
A previous study has suggested an analgesic effect of
ER-Bup, however the pain evaluations consisted of two
non-validated subjective pain scales [23] and no placebo
group. In contrast, our study showed a clear analgesic
effect over a 72 h period postoperatively using objective
measures and a control group comparison.
However, a weakness of our study is that the subjective
scoring system used was not one of the partially validated
subjective pain scales currently available [14, 16–18]. This
was because the study was performed before most of the
information on these scales was published. Additionally,
the assessment tools that have been produced thus far
Table 7 Kinetic data collected during walking in the control
group
Time SI PVF SI VI
P-value <0.0001 <0.0001
0 2.20 ± 13.43 4.54 ± 12.17
6 (−73.00 ± 49.92)* (−112.32 ± 43.53)*
24 (−25.39 ± 20.54)* (−40.87 ± 24.84)*
30 (−41.43 ± 25.83)* (−54.12 ± 31.04)*
48 (−31.69 ± 21.16)* (−59.40 ± 31.47)*
54 (−52.48 ± 44.68)* (−80.71 ± 54.10)*
72 (−31.82 ± 19.04)* (−65.90 ± 31.35)*
Mean ± SD, *indicates significant difference from baseline (<0.05)
Fig. 5 Effect of treatment with ER-Bup on landing kinetic data. a Peak vertical force (PVF) for operated limb (OP); b Vertical impulse (VI) for OP; c
Symmetry indices (SI) for PVF; d SI for VI. Assessments were made 24 and 48 h initial and second surgery (baseline) and 6, 24, 30, 48, 54, and 72 h
after surgery. The average baseline value was subtracted from the measured value at each time point in the analysis. Line graphs showing the
changes from baseline in each gait parameter over study period. The mean difference ± SD in control group and extended release formulation of
buprenorphine HCL (ER-Bup) group at various time points after onychectomy (n = 4). Orange solid line is control group, blue dotted line is ER-Bup
group. Negative value of SI means the cat put less weight on operated limb after surgery.* indicates significant difference between groups (<0.05)
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have been developed for client-owned cats, not research
cats. Although there is no data on this subject, our obser-
vations are that research cats are less demonstrative
than client-owned cats and other unpublished obser-
vations indicate these subjective tools are less sensi-
tive in research cats than client-owned cats, similar to
the situation in dogs [22].
Kinetic parameters measured using a PSW in cats dur-
ing walking have been used to evaluate the effectiveness
of analgesics for acute and chronic pain [21, 26, 27].
However, although several reports have evaluated gait
symmetry and limb loading in cats, some of them have
accepted the data generated even if a limb only con-
tacted the walkway once or twice [26, 28] and wide
ranges of velocity are accepted [19]. The present study
highlighted the difficulty in collecting walking data from
freely moving cats as velocity cannot be easily con-
trolled, and in some cases, cats in the saline treatment
Fig. 6 Summary symmetry indices values for kinetic data in the control group during walking. a Symmetry indices (SI) for Peak vertical force
(PVF); b SI for Vertical impulse (VI). Line graphs showing the mean ± SD in control group at various time points before and after onychectomy in
four walking cats. Time point 0 h is the mean of assessments at 24 and 48 h prior to surgery (baseline). The gait parameters were recorded at 6,
24, 30, 48, 54, and 72 h following surgery. The SI of 0 means there is perfect symmetry between the forelimbs, the value of −200 means the cat is
non-weight bearing on the operated limb. *indicates significant difference from baseline (<0.05)
Table 8 Kinetic data (mean ± SD) collected during walking in the control and ER-Bup groups
Treatment groups Treatment effect
Variable Control ER-Bup P-values Group difference in time
SI for PVF (−54.61 ± 27.98) (−41.57 ± 22.03) 0.0002* ER-Bup > control at 6, 54 h
SI for VI (−36.33 ± 25.59) (−26.13 ± 21.89) <.0001* ER-Bup > control at 6, 54 h
*indicates significant difference between groups (<0.05)
PVF Peak vertical force, VI vertical impulse, SI symmetry indices, ER-Bup extended release formulation of buprenorphine HCL
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group refused to walk. Variation in velocity is a well-
known factor that influences the kinetic data during
walking [29, 30]. Conversely, landing data are easily col-
lected, although this approach is not likely to be useful
to assess hindlimb pain.
Although there were significant differences between
baseline and postoperative period in Tf1f2 and NTf1f2,
significant differences were not observed between the
two treatment groups. The coarseness of data collection
may have contributed to the lack of difference. The fre-
quency of data acquisition was limited to 60 Hz using
the PSW and so a single frame is equivalent to 0.017 s.
This frequency of data acquisition might be not fast
enough to detect changes in the time between first fore-
limb and second forelimb strike.
A significant increase in Tf1h1 was detected after sur-
gery and values were significantly longer in the control
group. At first glance, this is counter intuitive – one
would expect that a cat landing from a jump, and with a
painful forelimb, would more quickly bring the hin-
dlimbs down to the ground. In order to try to explain
this, we retrospectively evaluated the videos captured
during the study, and we observed that cats in the con-
trol group appeared to jump down more vertically,
appearing to be trying to shorten the jump distance, but
conversely, appeared to spend longer on their forelimbs
following jumping. Cats in the ER-Bup group tended to
jump more normally, jumping out, away from the plat-
form, and thus the hindlimbs made contact with the
PSW more quickly. These observations are detailed in
Fig. 7 Effect of the treatment on symmetry indices values for kinetic data during walking. a Symmetry indices (SI) for Peak vertical force (PVF); b
SI for Vertical impulse (VI). Assessments were made 24 and 48 h initial and second surgery (baseline) and 6, 24, 30, 48, 54, and 72 h after surgery.
The difference between this average baseline value and the measured value were calculated at each time point in the analysis. Line graphs showing
the mean difference ± SD in control group and extended release formulation of buprenorphine HCL (ER-Bup) group at various time points
after onychectomy (n = 4). Orange solid line is control group, blue dotted line is ER-Bup group. Negative value of SI means the cat put less
weight on operated limb after surgery.* indicates significant difference between groups (<0.05)
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Fig. 8. However, these, observations need to be evaluated
using a higher frequency of data capture and methods to
measure the distance from the perch to the point of
landing on the PSW.
Surprisingly, landing VI for the operated limb in the
control group was significantly closer to baseline than
VI in the ER-Bup group even though PVF for operated
limb in the control group was significantly lower than in
the ER-Bup group. Additionally, landing VI of the ER-
Bup group was significantly lower than landing VI of the
control group. Lower VI during walking and trotting in
dogs has been associated with pain and lameness. Our
apparently contradictory results for the landing data ap-
pears to be due to the contact time. The contact time
for operated limb in the control group was longer than
in the ER-Bup group (see Additional files 5 and 6). Vertical
impulse is defined as the area under the force by time
curve. Thus, if contact time is longer, VI may be larger than
in another case where force is higher but contact time is
shorter. All our other data indicates a positive benefit from
the administration of ER-Bup, and therefore we hypothesize
that the reason for the longer contact time for operated
limb in the control group may be related to a similar
phenomenon in humans – humans prefer lower pain for
longer, than higher pain for shorter time periods [31]. As
described above, the way the cats chose to jump down from
the elevated platform may help explain our data.
Limitations of this study include the very small num-
ber of the cats evaluated, and the variations in velocity
during walking. The small sample size limits statistical
power. To minimize the effect of velocity on PVF and
VI, velocity should be restricted to a tight range [29, 30].
We used SI as a means of diminishing the effect of
velocity, however, it is not known if symmetry indices
are affected by velocity in lame animals and this needs
investigation.
Conclusions
In summary, our hypotheses were supported. Unilateral
onychectomy resulted in asymmetry of forelimb kinetic
values in cats, and ER-Bup decreased this asymmetry, sug-
gesting SC administration of ER-Bup may be an effective
analgesic over a 72-h period postoperatively. Further,
data indicate jumping down onto a PSW may be a
useful and efficient way of assessing analgesics in cats
if a unilateral model of limb pain is used. Further
studies are needed to extend our understanding of
landing kinetic data in cats.
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